These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
487 related items for PubMed ID: 25855730
1. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice. Gromowski GD, Firestone CY, Whitehead SS. J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730 [Abstract] [Full Text] [Related]
2. Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2. Yang D, Li XF, Ye Q, Wang HJ, Deng YQ, Zhu SY, Zhang Y, Li SH, Qin CF. Vaccine; 2014 May 13; 32(23):2675-81. PubMed ID: 24709585 [Abstract] [Full Text] [Related]
3. A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice. Yun SI, Song BH, Kim JK, Yun GN, Lee EY, Li L, Kuhn RJ, Rossmann MG, Morrey JD, Lee YM. PLoS Pathog; 2014 Jul 13; 10(7):e1004290. PubMed ID: 25077483 [Abstract] [Full Text] [Related]
4. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). Arroyo J, Guirakhoo F, Fenner S, Zhang ZX, Monath TP, Chambers TJ. J Virol; 2001 Jan 13; 75(2):934-42. PubMed ID: 11134306 [Abstract] [Full Text] [Related]
5. Comparison of the live-attenuated Japanese encephalitis vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo. Yun SI, Song BH, Polejaeva IA, Davies CJ, White KL, Lee YM. J Gen Virol; 2016 Oct 13; 97(10):2575-2591. PubMed ID: 27498826 [Abstract] [Full Text] [Related]
6. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities. Yu Y. Vaccine; 2010 May 07; 28(21):3635-41. PubMed ID: 20226891 [Abstract] [Full Text] [Related]
8. The A66G back mutation in NS2A of JEV SA14-14-2 strain contributes to production of NS1' protein and the secreted NS1' can be used for diagnostic biomarker for virulent virus infection. Wang J, Li X, Gu J, Fan Y, Zhao P, Cao R, Chen P. Infect Genet Evol; 2015 Dec 07; 36():116-125. PubMed ID: 26384477 [Abstract] [Full Text] [Related]
9. Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus. Liu X, Zhao D, Jia L, Xu H, Na R, Ge Y, Liu S, Yu Y, Li Y. Vaccine; 2018 Jul 25; 36(31):4650-4656. PubMed ID: 29954631 [Abstract] [Full Text] [Related]
10. [Construction of infectious Japanese encephalitis virus clone based on the cDNA template of the attenuated live vaccine production strain SA14-14-2]. Zeng M, Jia LL, Yu YX, Dong GM, Liu WX, Wang ZW, Li DF. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar 25; 19(1):9-11. PubMed ID: 16201461 [Abstract] [Full Text] [Related]
19. Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans. Song BH, Yun GN, Kim JK, Yun SI, Lee YM. J Microbiol; 2012 Aug 25; 50(4):698-706. PubMed ID: 22923123 [Abstract] [Full Text] [Related]